Affordable Access

Transforming growth factor alpha- and c-myc-induced mammary carcinogenesis in transgenic mice.

Authors
  • Rose-Hellekant, T A
  • Sandgren, E P
Type
Published Article
Journal
Oncogene
Publisher
Springer Nature
Publication Date
Feb 21, 2000
Volume
19
Issue
8
Pages
1092–1096
Identifiers
PMID: 10713695
Source
Medline
License
Unknown

Abstract

The growth factor transforming growth factor alpha (TGFalpha) and the nuclear transcription factor c-myc often are overexpressed by human breast cancer cells. To produce models of breast disease with these etiologies, mice were generated that carried TGF-alpha- or c-myc-encoding transgenes. Transgene targeting employed the whey acidic protein (WAP) gene promoter, which is expressed in pregnant and lactating mammary epithelial cells. Non-virgin WAP-TGFalpha transgenic mice displayed accelerated mammary development during pregnancy, delayed post-parturient mammary involution, a progressive increase in the number of hyperplastic alveolar nodules (HANs), and development of mammary carcinoma with a mean latency of 9 months. Non-virgin WAP-c-myc transgenic mice displayed accelerated mammary gland development during pregnancy and development of mammary carcinomas with a latency of 8 months. Bitransgenic mice carrying both WAP-TGFalpha and WAP-c-myc displayed a dramatic acceleration of tumor development. These models identify the overexpression of TGFalpha or c-myc as etiological factors in the development of mammary neoplasia and demonstrate the increased severity of disease when both molecular alterations are present in the same cell.

Report this publication

Statistics

Seen <100 times